Disruption of goblet cell function or marker expression—such as reduced Muc2 production—compromises this barrier, weakens mucosal defenses, and increases susceptibility to infections and chronic inflammatory diseases, including IBD and CRC [18,19]. The gene discussed is MUC2; the disease is colorectal carcinoma.